2. Value Proposition
Vital Vio has developed white lighting technology that can
safely provide environmental disinfection in a variety of
facilities that face bacteria problems or strive for a
cleaner environment.
Offering:
Safer environments
Financial savings
Improved patient care and comfort
Reduced illnesses in patients and staff
Marketing advantages

3. Sources of Contamination
Environmental Contamination
Transmission via Human Behavior
Infected Patient
Sick Person
Contaminated Goods
=

4. Current Solutions

5. Solution- Vital Vio Lighting Platform
Safe overhead lighting & disinfection for sensitive environments
• Consistent disinfection to reduce pathogenic microorganisms
• Safe for continuous use around people
• Retrofit LED unit for existing lighting
Daily reductions in bacteria, spores, fungus, yeast of up to 99.9% on exposed
surfaces

6. Benefits
 Effective
– 99.9% reduction: MRSA, E. Coli, C.Diff etc., verified by N.Y.S. Dept. of
Health
– Multiple journal published articles
 Safe
– Meets NIOSH, IEC, UL, ICNIR standards
– IEC62471-Photobiological Safety (UL)
 Easy Replacement
– For illumination standards
– For building and lighting code
Comparisons:
Fluorescent lighting
Vital Vio White with disinfection
wavelengths

7. Pathogens Killed by Vital Vio Spectrum
 Gram Positive Bacteria
• Staphylococcus aureus (inc. MRSA)
• Clostridium perfringens
• Clostridium difficile
• Enterococcus faecalis
• Staphylococcus epidermisdis (CONS)
• Staphylococcus hyicus (CONS)
• Streptococcus pyogenes
• Listeria monocytogenes
• Bacillus cereus
• Mycobacterium terrae
 Bacterial Endospores
• Bacillus cereus
• Clostridium difficile
 Gram Negative Bacteria
• Acinetobacter baumannii
• Pseudomonas aeruginosa
• Klebsiella pheumoniae
• Protus vulgaris
• Escherichia coli
• Salmonella enteritidis
• Shigella sonnei
• Serratia spp
 Yeast & Filamentous Fungi
• Aspergillus niger
• Candida albicans
• Saccharomyces cerevisiae

8. Results with Installed Ceiling Fixtures
Staph. aureus cells treated with fluorescent light (1000 lux) 16 hrs
Staph. aureus cells treated with Vital Vio light (1000 lux) 16 hrs

9. Germicidal Efficacy
Gram-positive Gram-negative
C. Diff, B. cereus, S. aureus

10. Ongoing Case Studies
Mt. Sinai Medical Center: Pilot Hospital
Engineered Molding Technologies - Cleanrooms

11. Partners & Independent Verification
Selected to receive 2 Advanced
Building PON Awards

12. Marketing Advantages
Patient Awareness
Brand Recognition
Mandated Satisfaction
Surveys
Competitive Advantage

13. Benefit of Reducing Infections
Reputation:
Consumer based
decisions
Reduce the cost of
readmission
Economic
Imperative
Avoid litigation
Affordable Care Act:
Penalties for
infection rates
“Reducing HAIs offers a very real opportunity to reduce operating costs while
maximizing reimbursements and avoiding future penalties.”
-VP Government & Industry Affairs at GE Healthcare

14. Vital Vio, Inc.
291 River St.
Troy, New York
Colleen Costello, CEO
costello@vitalvio.com
(914) 844-1629